Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients

Cancer, 04/23/2012

The current results indicated that a genome–wide pharmacogenomic approach is useful for identifying novel polymorphism predictors of severe oxaliplatin–induced chronic peripheral neuropathy (OXCPN) that may be used in personalized chemotherapy.

Print Article Summary Cat 2 CME Report